Trials / Completed
CompletedNCT02092597
Safety Evaluation of Adverse Reactions in Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effects of incretin-based antidiabetic therapies (DPP-4 inhibitors and GLP-1 agonists) on cardiovascular, gastrointestinal and renal system and to detail the mechanisms underlying their action in these systems.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exenatide | |
| DRUG | Linagliptin | |
| DRUG | Gliclazide |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-10-01
- Completion
- 2016-09-01
- First posted
- 2014-03-20
- Last updated
- 2018-02-07
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT02092597. Inclusion in this directory is not an endorsement.